Viewing Study NCT07235527

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 5:05 AM
Ignite Modification Date: 2026-01-04 @ 4:08 PM
Study NCT ID: NCT07235527
Status: RECRUITING
Last Update Posted: 2025-12-08
First Post: 2025-11-14
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Real-Life Clinical Outcomes of Aflibercept Biosimilar MY-1701P in the Treatment of Exudative Age-Related Macular Degeneration
Sponsor: Saglik Bilimleri Universitesi
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Age Related Macular Degeneration View
None Exudative Age-Related Macular Degeneration View
None Anti Vascular Endothelial Growth Factor View
Keywords:

Keywords

Keyword Brief Keyword Text View
None age related macular degeneration View
None anti vascular endothelial growth factor View
None anti-VEGF View
None aflibercept View
None macular neovascularization View
None aflibercept biosimilar View